Conversely, IL-15RαTAMs can reduce the protein level of the chemokine CX3CL1 in tumor cells by releasing the IL-15/IL-15Rα complex (IL-15Rc), inhibiting the recruitment of CD8+T cells (30). Here, CD8A is linked to neoplasm.